Cassava Sciences, Inc. (SAVA)
2.28
0.00 (0.00%)
USD |
NASDAQ |
Mar 02, 13:59
Cassava Sciences EPS Diluted (Quarterly) : -0.2237 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| cbdMD, Inc. | -0.036 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
| NovaBay Pharmaceuticals, Inc. | -1.100 |
| Spero Therapeutics, Inc. | -0.1312 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.81M |
| Total Expenses (Quarterly) | 10.81M |
| Enterprise Value | 4.062M |
| Earnings Yield | -96.40% |
| Normalized Earnings Yield | -96.39 |